Gallium nitrate for the treatment of non-Hodgkin’s lymphoma

10.3322/canjclin.53.1.5

10.1634/theoncologist.6-3-247

10.1016/S0093-7754(03)00235-5

10.1182/blood-2002-06-1793

EDWARDS CL, 1969, J. Nucl. Med., 10, 103

10.1016/S0001-2998(05)80007-8

10.1007/s002770050161

10.1073/pnas.68.7.1623

ADAMSON RH, 1975, Cancer Cheinother. Rep., 59, 599

NEWMAN RA, Cancer, 1979, 1728

WEICK JK, 1983, Cancer Treat. Rep., 67, 823

10.1002/1097-0142(19830601)51:11<1982::AID-CNCR2820511104>3.0.CO;2-L

KELLER J, 1986, Cancer TreaiRep., 70, 1221

WARRELL RP Jr, DANIEU L, COONLEY CJ, ATKINS C, 1987, Cancer Treat. Rep., 71, 47

10.1097/00000421-199704000-00015

10.1016/S0093-7754(03)00174-X

BERNSTEIN LR, 1998, Pharmacol Rev, 50, 665

10.1016/S1040-8428(01)00225-6

10.1021/bi00271a010

VALLABHAJOSULA SR, 1980, Nucl. Med., 21, 650

HARRIS AW, 1977, Cancer Res, 37, 3634

10.1016/0277-5379(82)90212-7

10.1172/JCI112746

CHITAMBAR CR, 1983, Effects of gallium and dimethylsulfoxide. Gin. Invest., 72, 1314

CHITAMBAR CR, 1987, Cancer Res, 47, 3929

CHAN SM, 1987, ' Nucl. Med., 28, 1303

CHITAMBAR CR, 1990, Cancer Res, 50, 1484

CHITAMBAR CR, 1992, Blood, 80, 505, 10.1182/blood.V80.2.505.bloodjournal802505

KATSIR, 1997, Cancer, 10, 43

KOVARJ SELIGMAN P, 1990, Cancer Res., 50, 5727

SELIGMAN PA, 1993, Blood, 82, 1608, 10.1182/blood.V82.5.1608.1608

CHITAMBAR CR, Blood, 1988, 1930

HEDLEY DW, 1988, Cancer Res., 48, 3014

10.1159/000163609

10.1146/annurev.bi.48.070179.001025

PETERSSON L, 1980, Biol. Chem., 255, 6706, 10.1016/S0021-9258(18)43628-9

10.1289/ehp.8564139

10.1016/0006-2952(92)90686-D

CHITAMBAR CR, 1991, Cancer Res, 51, 6199

WAALKES TP, 1974, Cancer Res, 34, 385

BERGGREN MM, 1993, Cancer Res., 53, 1862

ANGHILERI LJ, 1982, Nuklearmedizin, 21, 114, 10.1055/s-0037-1620562

10.1097/00001813-199906000-00008

LUNDBERG JL, 1990, Cancer Res, 50, 6466

10.1016/S0304-3835(98)00104-9

CHITAMBAR CR, 1994, Cancer Res., 54, 3224

HATA Y, 1994, Oncol Res., 6, 19

WARRELL RP Jr, ALCOCK NW, BOCKMAN RS, 1987, ' Clin. Oncol, 5, 292, 10.1200/JCO.1987.5.2.292

WARRELL RP Jr, LOVETT D, DILMANIAN FA, SCHNEIDER R, HEELAN RT, 1993, ' Clin. Oncol, 11, 2443, 10.1200/JCO.1993.11.12.2443

10.1016/S0093-7754(03)00170-2

WARRELL RP Jr, 1991, Semin.Oncol, 18, 26

10.2165/00003495-199142020-00007

MATKOVIC V, 1991, Carr. Ther. Res., 50, 255

DROBYSKI WR, 1996, Blood, 88, 3056, 10.1182/blood.V88.8.3056.bloodjournal8883056

10.1016/0165-5728(92)90186-O

CHITAMBAR CR, 1989, Cancer Res., 49, 1125

10.1007/BF01757356

PELOSI E, 1986, Biol. Chem., 261, 3036, 10.1016/S0021-9258(17)35742-3

FUTRAN J, 1989, Immunol, 143, 787, 10.4049/jimmunol.143.3.787

10.1002/1097-0142(19801101)46:9<2009::AID-CNCR2820460919>3.0.CO;2-A

10.1002/1097-0142(197911)44:5<1722::AID-CNCR2820440528>3.0.CO;2-C

SAMSON MK, 1980, Cancer Gin. Trials, 3, 131

BEDIKIAN AY, 1978, Cancer Treat. Rep., 62, 1449

10.1016/S0140-6736(83)92191-8

ESSERMAN L, 1989, Blood, 74, 2718, 10.1182/blood.V74.8.2718.2718

RADICE PA BUNN PAJ, 1979, Cancer Treat.Rep., 63, 1231

CARTER SK, 1975, Natl. Cancer Inst., 55, 1265, 10.1093/jnci/55.6.1265

CAVALLI F, Cancer, 1981, 1927

RODRIGUEZ V, 1978, Cancer Treat. Rep., 62, 439

KANTARJIAN H, 1983, Clin. Oncol, 1, 689, 10.1200/JCO.1983.1.11.689

REDMAN JR, 1992, Clin. Oncol, 10, 790, 10.1200/JCO.1992.10.5.790

O'BRIEN ME, 1994, Fludarabine in lymphoproliferative disorders: the Royal Marsden Hospital experience. Leak. Lymphoma, 14, 17

10.7326/0003-4819-120-9-199405010-00010

HOFFMAN M, 1994, I Clin. Omni, 12, 788

MALONEY DG, 1997, Blood, 90, 2188, 10.1182/blood.V90.6.2188

CHITAMBAR CR, 1990, Cancer Res., 50, 4468